Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Diseases of the Thyroid

Free Subscription Articles published in Surgery Retrieve available abstracts of 88 articles: HTML format

Single Articles

October 2025
1. NIGAM A, Mederos MA, Aksoy YA, Alzumaili B, et al
   Multifocality in sporadic medullary thyroid carcinoma is associated with low tumor grade and no difference in somatic driver mutations or overall survival when compared with unifocal tumors.
   Surgery. 2025 Oct 9:109764. doi: 10.1016/j.surg.2025.109764.
   PubMed     Abstract available
   
   
   
2. FIGUEROA-BOHORQUEZ D, Marulanda M, Betancourt C, Garcia C, et al
   Surgeon-performed transcutaneous laryngeal ultrasonography after thyroidectomy: Diagnostic accuracy and learning curve.
   Surgery. 2025;188:109779.
   PubMed     Abstract available
   
   
   
3. KOELLIKER EL, Krumeich LN, Kravchenko T, Keamy Blanco MM, et al
   Sonographic and pathologic features of malignant hot thyroid nodules: A multi-institutional study.
   Surgery. 2025 Oct 7:109710. doi: 10.1016/j.surg.2025.109710.
   PubMed     Abstract available
   
   
   
4. JAISWAL S, Yamashita A, Lee S, Amirfakhri S, et al
   Sprayable pH-sensitive near-infrared fluorophore for rapid, bright, specific, and safe visualization of human thyroid cancer in orthotopic mouse models.
   Surgery. 2025 Oct 6:109703. doi: 10.1016/j.surg.2025.109703.
   PubMed     Abstract available
   
   
   
5. BAUZON J, Shin J, Plitt G, Perez-Soto R, et al
   Validation of molecular profiling to preoperatively predict aggressive pathologic features in differentiated thyroid cancer.
   Surgery. 2025 Oct 6:109698. doi: 10.1016/j.surg.2025.109698.
   PubMed     Abstract available
   
   
   
6. FUNG MHM, Luk Y, Lang BHH
   A prospective comparison of sequential versus interval retreatment with radiofrequency ablation for predominantly solid, large-volume benign thyroid nodules.
   Surgery. 2025 Oct 3:109763. doi: 10.1016/j.surg.2025.109763.
   PubMed     Abstract available
   
   
   September 2025
7. SATHE SV, Chmiel A, Jones C, Gillanders WE, et al
   Deviating from Thyroid Imaging Reporting and Data Systems (TI-RADS) guidelines in surgical planning for patients with parathyroid disease: What is the clinical impact?
   Surgery. 2025 Sep 30:109705. doi: 10.1016/j.surg.2025.109705.
   PubMed     Abstract available
   
   
   
8. PLITT G, Mitzukami T, Yehia L, Rabinowitz L, et al
   Targeted RNA sequencing of thyroid tumors from individuals with PTEN hamartoma tumor syndrome reveals a unique transcriptome with a predominantly RAS-like expression profile.
   Surgery. 2025 Sep 29:109697. doi: 10.1016/j.surg.2025.109697.
   PubMed     Abstract available
   
   
   
9. FUNG MHM, Cheng CC, Luk Y, Lang BHH, et al
   Laryngeal ultrasound-guided adhesive transcutaneous electrodes versus conventional endotracheal electrodes for intraoperative neuromonitoring during thyroid and neck surgery.
   Surgery. 2025 Sep 29:109709. doi: 10.1016/j.surg.2025.109709.
   PubMed     Abstract available
   
   
   
10. KOWALSKI R, Carlisle K, Park AN, Ricci S, et al
    Patient preferences in papillary thyroid microcarcinoma management are driven by aversion toward complications rather than treatment pathway.
    Surgery. 2025 Sep 25:109694. doi: 10.1016/j.surg.2025.109694.
    PubMed     Abstract available
    
    
    August 2025
11. MICHAELSEN SH, Dossing H, Gerke O, Bjorndal K, et al
    Combined near-infrared autofluorescence and preresection indocyanine green angiography for parathyroid gland preservation during thyroid surgery: A clinical controlled trial.
    Surgery. 2025;187:109623.
    PubMed     Abstract available
    
    
    
12. GHANI A, Al Darwashi LM, Hajeir MY, Ayesh AR, et al
    Clinical impact of obesity on thyroidectomy outcomes: A systematic review and meta-analysis.
    Surgery. 2025;186:109598.
    PubMed     Abstract available
    
    
    July 2025
13. VAGHAIWALLA TM, Henriksen EM, Chang J, Saghira C, et al
    Reassessing false-negative rate and size cutoff for papillary thyroid cancer with fine-needle aspiration in thyroid nodules.
    Surgery. 2025;186:109577.
    PubMed     Abstract available
    
    
    March 2025
14. VAGHAIWALLA TM, Lew JI
    Letter to the editor regarding: "Impact of chronic lymphocytic thyroiditis on the diagnostic and intraoperative management of papillary thyroid cancer".
    Surgery. 2025 Mar 22:109337. doi: 10.1016/j.surg.2025.109337.
    PubMed    
    
    
    
15. LOPERA K, Sanabria A
    Threshold-dependent risk of postoperative hypocalcemia in vitamin D-deficient patients undergoing total thyroidectomy: A meta-analysis.
    Surgery. 2025;182:109333.
    PubMed     Abstract available
    
    
    February 2025
16. PAPINI P, Rossi L, Matrone A, De Renzis A, et al
    Prophylactic central neck dissection in clinically node-negative papillary thyroid carcinoma: 10-year impact on surgical and oncologic outcomes.
    Surgery. 2025;181:109258.
    PubMed     Abstract available
    
    
    
17. AN R, Yun D
    Letter to the editor regarding: "Impact of chronic lymphocytic thyroiditis on the diagnostic and intraoperative management of papillary thyroid cancer".
    Surgery. 2025 Feb 15:109251. doi: 10.1016/j.surg.2025.109251.
    PubMed    
    
    
    
18. NGO S, Hu TX, Zhu CY, Hughes EG, et al
    Utility of prophylactic central dissection in papillary thyroid carcinoma with clinically apparent lymph node metastases isolated to the lateral neck.
    Surgery. 2025;181:109160.
    PubMed     Abstract available
    
    
    January 2025
19. MORENO LLORENTE P, Alberich Prats M, Garcia Barrasa A, Pascua Sole M, et al
    Postoperative and permanent hypocalcemia after indocyanine green (ICG) angiography-guided total thyroidectomy and central neck dissection: A retrospective cohort study.
    Surgery. 2025;181:109142.
    PubMed     Abstract available
    
    
    
20. GLOVER A
    Response: Letter to the editor: "Oncogenic mutations in the TP53 and PI-3 kinase/AKT pathway are independent predictors of survival for advanced thyroid cancer: Analysis from the Molecular Screening and Therapeutics (MoST) program".
    Surgery. 2025 Jan 3:109006. doi: 10.1016/j.surg.2024.109006.
    PubMed    
    
    
    December 2024
21. JI X, Liang W, Yu T, Ding C, et al
    Thyroid lobectomy for unilateral TNM T1 and T2 papillary thyroid carcinoma patients with lateral lymph node metastasis.
    Surgery. 2024;180:109028.
    PubMed     Abstract available
    
    
    
22. PENNESTRI F, Procopio PF, De Crea C, Raffaelli M, et al
    Response letter to the editor: "Is desmoplastic stromal reaction useful to modulate lymph node dissection in sporadic medullary thyroid carcinoma?".
    Surgery. 2024 Dec 19:109001. doi: 10.1016/j.surg.2024.109001.
    PubMed    
    
    
    
23. VAGHAIWALLA TM, DeTrolio V, Saghira C, Akcin M, et al
    Impact of chronic lymphocytic thyroiditis on the diagnostic and intraoperative management of papillary thyroid cancer.
    Surgery. 2024 Dec 16:108937. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
24. MACHENS A, Dralle H
    Letter to the editor: "Is desmoplastic stromal reaction useful to modulate lymph node dissection in sporadic medullary thyroid carcinoma?".
    Surgery. 2024 Dec 6:108960. doi: 10.1016/j.surg.2024.108960.
    PubMed    
    
    
    
25. WANG W, Wang H, Chen X
    Letter to the editor on "Oncogenic mutations in the TP53 and PI-3 kinase/AKT pathway are independent predictors of survival for advanced thyroid cancer: Analysis from the Molecular Screening and Therapeutics (MoST) program".
    Surgery. 2024 Dec 6:108959. doi: 10.1016/j.surg.2024.108959.
    PubMed    
    
    
    November 2024
26. CHEREAU N, Gaujoux S, Ghander C, Bertocchio JP, et al
    Parathyroid hormone-based algorithm reduces complications after total thyroidectomy.
    Surgery. 2024 Nov 28:108933. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
27. PLOTZL A, Wicher A, Jarosz M, Passler C, et al
    A large single-center analysis of postoperative hemorrhage in more than 43,000 thyroid operations: The relevance of intraoperative systolic blood pressure, the individual surgeon, and surgeon-to-patient gender (in-)congruence.
    Surgery. 2024 Nov 15:108910. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    October 2024
28. PRATT CG, Long SA, Whitrock JN, Holm TM, et al
    "Thanks, but no thanks": Factors associated with patients who decline surgical intervention for thyroid cancer.
    Surgery. 2024 Oct 30:S0039-6060(24)00837-7. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
29. DICKERSON K, Milas M, Metzger R, Tomeh C, et al
    Neoadjuvant systemic therapy for inoperable differentiated thyroid cancers: Impact on tumor resectability.
    Surgery. 2024 Oct 28:S0039-6060(24)00706-2. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
30. CRAIG S, Stretch C, Yeo C, Fan J, et al
    Prognostication with Thyroid GuidePx in the context of tall cell variants.
    Surgery. 2024 Oct 25:S0039-6060(24)00810-9. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
31. PROCOPIO PF, Pennestri F, Voloudakis N, La Rocca S, et al
    Is desmoplastic stromal reaction useful to modulate lymph node dissection in sporadic medullary thyroid carcinoma?
    Surgery. 2024 Oct 24:S0039-6060(24)00809-2. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
32. FUNG MHM, Luk Y, Lang BHH
    Early second radiofrequency ablation treatment gave rise to significantly greater nodule shrinkage at 12 months than single-session treatment for large-volume benign thyroid nodules.
    Surgery. 2024 Oct 24:S0039-6060(24)00807-9. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
33. WILLIAMS JE, Sinha A, Pitt SC, Hughes DT, et al
    It's not that SIMPL-Identifying deficiencies in general surgery trainees' autonomy and competence performing parathyroidectomy and thyroidectomy.
    Surgery. 2024 Oct 18:S0039-6060(24)00780-3. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
34. NOVIS E, Glover A, Grady JP, Silvestri A, et al
    Oncogenic mutations in the TP53 and PI-3 kinase/AKT pathway are independent predictors of survival for advanced thyroid cancer: Analysis from the Molecular Screening and Therapeutics (MoST) program.
    Surgery. 2024 Oct 17:S0039-6060(24)00781-5. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
35. RAGHUNATHAN R, Jacobs AR, Sant VR, King LJ, et al
    Can large language models address unmet patient information needs and reduce provider burnout in the management of thyroid disease?
    Surgery. 2024 Oct 17:S0039-6060(24)00782-7. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
36. CARNABATU CJ, Fetzer DT, Tessnow A, Holt S, et al
    Avoidable biopsies? Validating artificial intelligence-based decision support software in indeterminate thyroid nodules.
    Surgery. 2024 Oct 12:S0039-6060(24)00697-4. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
37. ENGELBRECHT-WIGGANS EA, Carlisle K, Yunasan E, Fan C, et al
    Long-term retreatment outcomes after definitive management of Graves' disease with radioactive iodine versus surgery.
    Surgery. 2024 Oct 10:S0039-6060(24)00699-8. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
38. TUMATI A, Marshall TE, Greenspun B, Chen Z, et al
    Evaluating the clinical performance of an updated microRNA classifier in indeterminate and RAS-mutated thyroid nodule management: A multi-institutional study.
    Surgery. 2024 Oct 10:S0039-6060(24)00704-9. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
39. ZHAO HH, Wilhelm SM
    Exploring ethnic diversity and clinical outcome variabilities in well-differentiated thyroid cancer among the Asian population.
    Surgery. 2024 Oct 8:S0039-6060(24)00698-6. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
40. KURTOM S, Liu JB, Doerfler WR, Calcaterra M, et al
    Tumor size and molecular risk group are associated with differentiated thyroid cancer recurrence.
    Surgery. 2024 Oct 8:S0039-6060(24)00710-4. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
41. COLLINS RA, McManus C, Kuo EJ, Liou R, et al
    Improvement in thyroid-specific quality of life following radiofrequency ablation of benign thyroid nodules: A USA study.
    Surgery. 2024 Oct 8:S0039-6060(24)00693-7. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
42. ARTHURS L, Fredericks S, Attlassy Y, Raghunathan R, et al
    Language-based exclusion associations with racial and ethnic disparities in thyroid cancer clinical trials.
    Surgery. 2024 Oct 7:S0039-6060(24)00696-2. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    September 2024
43. BRAAFLADT S, Allison H, Chung J, Mariash CN, et al
    Dose-dependent relationship between levothyroxine and health-related quality of life in survivors of differentiated thyroid cancer.
    Surgery. 2024 Sep 27:S0039-6060(24)00647-0. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
44. OH MY, Park D, Chai YJ, Kim K, et al
    Transoral robotic thyroidectomy: Lessons learned from consecutive series of 1,000 patients.
    Surgery. 2024 Sep 17:S0039-6060(24)00583-X. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
45. MELIN SJH, Park SY, Shaker J, Yen TWF, et al
    Evaluation for primary hyperparathyroidism after radioactive iodine treatment in patients with Graves' disease.
    Surgery. 2024 Sep 9:S0039-6060(24)00567-1. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    August 2024
46. MACHENS A, Dralle H
    Response to letter to the editor on "Sporadic noninvasive medullary thyroid neoplasm: A desmoplasia-negative, unifocal, nonmetastatic tumor cured by hemithyroidectomy".
    Surgery. 2024 Aug 30:S0039-6060(24)00222-8. doi: 10.1016/j.surg.2024.
    PubMed    
    
    
    
47. KIM LT
    Invited commentary on: YMSY-D-23-01181_R2. Overexpression of human DNA polymerase theta (POLQ) is a biomarker of aggressive and DNA repair-deficient papillary thyroid cancers.
    Surgery. 2024 Aug 20:S0039-6060(24)00543-9. doi: 10.1016/j.surg.2024.
    PubMed    
    
    
    
48. AKGUN E, Uysal M, Avci SN, Berber E, et al
    The use of artificial intelligence to detect parathyroid tissue on ex vivo specimens during thyroidectomy and parathyroidectomy procedures using near-infrared autofluorescence signals.
    Surgery. 2024 Aug 14:S0039-6060(24)00494-X. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    July 2024
49. FEBRERO SANCHEZ B, Iborra E, Sanchez-Pedreno P, Ros-Madrid I, et al
    Analysis of the loss of phosphatase and tensin homolog expression in thyroid tissue for the diagnosis of Cowden syndrome.
    Surgery. 2024 Jul 6:S0039-6060(24)00384-2. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    June 2024
50. FRYE CC, Tennant L, Yeager A, Azimzadeh P, et al
    Overexpression of human DNA polymerase theta is a biomarker of aggressive and DNA repair-deficient papillary thyroid cancers.
    Surgery. 2024 Jun 18:S0039-6060(24)00303-9. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
51. LUK Y, Fung MMH, Lui DTW, Liu X, et al
    Long-term kidney outcomes in patients with permanent hypoparathyroidism after total thyroidectomy for benign disease: A population-based study.
    Surgery. 2024 Jun 15:S0039-6060(24)00302-7. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    May 2024
52. BAKLACI M, Eyigor S
    Comments on "Prevalence and risk factors for dysphagia in older adults after thyroid and parathyroid surgery".
    Surgery. 2024 May 31:S0039-6060(24)00184-3. doi: 10.1016/j.surg.2024.
    PubMed    
    
    
    
53. XIAO X, Zhu Y, Li L, Liao Y, et al
    The effectiveness and safety of thermal ablation for thyroid carcinoma lymph node metastasis are affected by the diameter of metastatic lymph nodes: A meta-analysis.
    Surgery. 2024 May 21:S0039-6060(24)00233-2. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
54. MANZELLA A, Kheng M, Chao J, Laird AM, et al
    Association of Medicaid expansion with access to thyroidectomy for benign disease at high-volume centers.
    Surgery. 2024 May 17:S0039-6060(24)00228-9. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
55. MASCARENHAS R, Shamshery C, Dhiraj S, Agarwal G, et al
    Letter to the editor on: "Early observations with an ERAS pathway for thyroid and parathyroid surgery: Moving the goalposts forward".
    Surgery. 2024 May 17:S0039-6060(24)00221-6. doi: 10.1016/j.surg.2024.
    PubMed    
    
    
    
56. CREPEAU PK, Sutton W, Bandeen-Roche K, Walston JD, et al
    Reply to: "Comments on 'Prevalence and risk factors for dysphagia in older adults after thyroid and parathyroid surgery'".
    Surgery. 2024 May 14:S0039-6060(24)00186-7. doi: 10.1016/j.surg.2024.
    PubMed    
    
    
    April 2024
57. PAPAVRAMIDIS T, Chorti A, Cheva A
    Response to "Sporadic noninvasive medullary thyroid neoplasm: A desmoplasia-negative unifocal nonmetastatic tumor cured by hemithyroidectomy".
    Surgery. 2024 Apr 3:S0039-6060(24)00131-4. doi: 10.1016/j.surg.2024.
    PubMed    
    
    
    January 2024
58. HEO DB, Won HR, Tae K, Kang YE, et al
    Clinical impact of coexistent chronic lymphocytic thyroiditis on central lymph node metastasis in low- to intermediate-risk papillary thyroid carcinoma: The MASTER study.
    Surgery. 2024 Jan 27:S0039-6060(23)00967-4. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
59. LUND S, Schmitz JJ, Foster T, Dy B, et al
    Ethanol ablation of papillary thyroid carcinoma nodal metastases: Long-term outcomes.
    Surgery. 2024 Jan 8:S0039-6060(23)00908-X. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
60. LEE-SAXTON YJ, Palacardo F, Greenberg JA, Egan CE, et al
    Radioactive iodine administration is not associated with improved disease-specific survival in classic papillary thyroid carcinoma greater than 4 cm confined to the thyroid.
    Surgery. 2024;175:215-220.
    PubMed     Abstract available
    
    
    
61. WRIGHT K, Fisher JC, Rothberger GD, Prescott JD, et al
    Incidental (68)Ga-DOTATATE uptake in thyroid nodules: Is guideline-directed management still appropriate?
    Surgery. 2024;175:228-233.
    PubMed     Abstract available
    
    
    December 2023
62. YAMAMOTO M, Miyauchi A, Ito Y, Fujishima M, et al
    Tumor volume-doubling rate is negatively associated with patient age in papillary thyroid microcarcinomas under active surveillance.
    Surgery. 2023 Dec 22:S0039-6060(23)00887-5. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
63. CONROY PC, Wilhelm A, Rajwani T, Mulder M, et al
    Nerve monitoring in endocrine surgery: Practice patterns differ among surgeons for parathyroidectomy and thyroidectomy.
    Surgery. 2023 Dec 21:S0039-6060(23)00889-9. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
64. HU QL, Chen L, Kuo EJ, Lee JA, et al
    A national study of postoperative thyroid hormone supplementation rates after thyroid lobectomy.
    Surgery. 2023 Dec 13:S0039-6060(23)00871-1. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    November 2023
65. FINN CB, Sharpe JE, Krumeich LN, Ginzberg SP, et al
    The use and costs of same-day surgery versus overnight admission for total thyroidectomy: A multi-state, all-payer analysis.
    Surgery. 2023 Nov 20:S0039-6060(23)00625-6. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
66. CHAO JC, Kheng M, Manzella A, Beninato T, et al
    Malpractice litigation after thyroid surgery: What factors favor surgeons?
    Surgery. 2023 Nov 18:S0039-6060(23)00680-3. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
67. MACHADO N, Mortlock R, Maduka R, Souza Cunha AE, et al
    Early observations with an ERAS pathway for thyroid and parathyroid surgery: Moving the goalposts forward.
    Surgery. 2023 Nov 14:S0039-6060(23)00633-5. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
68. STURGEON C
    Addressing financial toxicity in thyroid cancer survivors in the United States.
    Surgery. 2023 Nov 10:S0039-6060(23)00755-9. doi: 10.1016/j.surg.2023.
    PubMed    
    
    
    
69. RUSSELL JO, Desai DD, Noel JE, Hussein M, et al
    Radiofrequency ablation of benign thyroid nodules: A prospective, multi-institutional North American experience.
    Surgery. 2023 Nov 10:S0039-6060(23)00725-0. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
70. VISENIO MR, Reddy S, Sturgeon C, Elaraj DM, et al
    Emergency department use after outpatient thyroidectomy across three states.
    Surgery. 2023 Nov 8:S0039-6060(23)00682-7. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
71. CREPEAU PK, Sutton W, Sahli Z, Fedorova T, et al
    Prevalence and risk factors for dysphagia in older adults after thyroid and parathyroid surgery.
    Surgery. 2023 Nov 8:S0039-6060(23)00672-4. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
72. RAGHUNATHAN R, Longstaff XR, Hughes EG, Li SJ, et al
    Diagnostic performance of molecular testing in indeterminate (Bethesda III and IV) thyroid nodules with Hurthle cell cytology.
    Surgery. 2023 Nov 3:S0039-6060(23)00634-7. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
73. LIN AC, Liu Z, Lee J, Ranvier GF, et al
    Generating a multimodal artificial intelligence model to differentiate benign and malignant follicular neoplasms of the thyroid: A proof-of-concept study.
    Surgery. 2023 Nov 2:S0039-6060(23)00635-9. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    October 2023
74. GIMBLET GR, Whitt J, Houson HA, Lin D, et al
    Thyroid-stimulating hormone receptor (TSHR) as a target for imaging differentiated thyroid cancer.
    Surgery. 2023 Oct 31:S0039-6060(23)00631-1. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
75. TUMATI A, Egan CE, Lee-Saxton YJ, Marshall TE, et al
    Clinical utility of a microRNA classifier in cytologically indeterminate thyroid nodules with RAS mutations: A multi-institutional study.
    Surgery. 2023 Oct 29:S0039-6060(23)00626-8. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
76. CARLISLE KM, Brown JP, Kim J, Turner DJ, et al
    Age-stratified comparison of active surveillance versus radiofrequency ablation for papillary thyroid microcarcinoma using decision analysis.
    Surgery. 2023 Oct 21:S0039-6060(23)00638-4. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
77. COLLINS RA, McManus C, Kuo EJ, Liou R, et al
    The impact of social determinants of health on thyroid cancer mortality and time to treatment.
    Surgery. 2023 Oct 21:S0039-6060(23)00627-X. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
78. ROMERO-VELEZ G, Avci SN, Isiktas G, Ergun O, et al
    Comparison of incidental parathyroid tissue detection rates on pathology after total thyroidectomy performed with or without near-infrared autofluorescence imaging.
    Surgery. 2023 Oct 20:S0039-6060(23)00639-6. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
79. HUSSEIN M, Toraih E, Issa PP, Omar M, et al
    From ablation to operation: Unraveling the surgical outcomes and complications of thyroidectomy after radiofrequency ablation.
    Surgery. 2023 Oct 20:S0039-6060(23)00629-3. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
80. ZHAO HH, Wilhelm SM
    Pediatric thyroid cancer: Socioeconomic disparities and their impact on access to care.
    Surgery. 2023 Oct 18:S0039-6060(23)00600-1. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
81. DRALLE H, Brandenburg T, Weber F, Fuhrer-Sakel D, et al
    Sporadic noninvasive medullary thyroid neoplasm: A desmoplasia-negative unifocal nonmetastatic tumor cured by hemithyroidectomy.
    Surgery. 2023 Oct 9:S0039-6060(23)00589-5. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    September 2023
82. ROMERO-VELEZ G, Noureldine SI, Burneikis T, Siperstein A, et al
    High-volume endocrine surgeons perform thyroid surgery at decreased cost despite increased case relative value units.
    Surgery. 2023 Sep 26:S0039-6060(23)00506-8. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
83. AKGUN E, Romero-Velez G, Berber E
    Assessing the efficacy of thyroid nodule radiofrequency ablation using patient-reported outcome measures.
    Surgery. 2023 Sep 21:S0039-6060(23)00514-7. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    August 2023
84. MONTGOMERY KB, Fazendin JM, Broman KK
    Evolving variation in the extent of surgery for low-risk papillary thyroid cancer in the United States.
    Surgery. 2023 Aug 5:S0039-6060(23)00428-2. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    June 2023
85. STEVENS A, Meier J, Bhat A, Knight SJ, et al
    Reassessing surgical guidelines for papillary thyroid cancer impact on survival: Expanding indications for lobectomy.
    Surgery. 2023 Jun 29:S0039-6060(23)00328-8. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    May 2023
86. KUO TC, Chen KY, Lai CW, Wang YC, et al
    Synergic evacuation device helps smoke control during endoscopic thyroid surgery.
    Surgery. 2023 May 16:S0039-6060(23)00187-3. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    April 2023
87. SAKOWITZ S, Bakhtiyar SS, Khoraminejad B, Ebrahimian S, et al
    Thyroid surgery outcomes in octogenarians: A national analysis.
    Surgery. 2023 Apr 11:S0039-6060(23)00053-3. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    March 2023
88. KANG YJ, Stybayeva G, Hwang SH
    Surgical completeness and safety of minimally invasive thyroidectomy in patients with thyroid cancer: A network meta-analysis.
    Surgery. 2023 Mar 25:S0039-6060(23)00110-1. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diseases of the Thyroid is free of charge.